Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoine Avignon

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Clinical Biochemistry|December 12, 2017
Triglycerides and glycated hemoglobin for screening insulin resistance in obese patientsGuilaine Boursier, Ariane Sultan, Nicolas Molinari, et al.
Plos One|April 2, 2015
Effects of lifestyle interventions that include a physical activity component in class II and III obese individuals: a systematic review and meta-analysisAurélie Baillot, Ahmed J Romain, Katherine Boisvert-Vigneault, et al.
Appetite|May 6, 2024
Development and validation of the mindful eating scale (mind-eat scale) in a general populationMarion Van Beekum, Rebecca Shankland, Angélique Rodhain, et al.
Oxidative Medicine and Cellular Longevity|June 1, 2018
No Additive Effects of Polyphenol Supplementation and Exercise Training on White Adiposity Determinants of High-Fat Diet-Induced Obese Insulin-Resistant RatsKaren Lambert, Marie Hokayem, Claire Thomas, et al.
Obesity (Silver Spring, Md.)|November 6, 2023
Semaglutide 2.4 mg/wk for weight loss in patients with severe obesity and with or without a history of bariatric surgeryJean-Baptiste Bonnet, Sarah Tournayre, Jean Anitcheou, et al.
Endocrine Connections|May 6, 2022
In patients with anorexia nervosa, myokine levels are altered but are not associated with bone mineral density loss and bone turnover alterationLaurent Maïmoun, Denis Mariano-Goulart, Helena Huguet, et al.
Obesity (Silver Spring, Md.)|April 3, 2025
Clustering of intuitive eating and psychological health identifies subgroups associated with weight loss following semaglutideAntoine Avignon, Jean-Baptiste Bonnet, Jean Anitcheou, et al.
Bone|May 16, 2021
Modification of bone mineral density, bone geometry and volumetric BMD in young women with obesityLaurent Maïmoun, Eric Renard, Ludovic Humbert, et al.
Medicina (Kaunas, Lithuania)|December 24, 2021
Compliance with Prescription Guidelines for Glucose-Lowering Therapies According to Renal Function: Real-Life Study in Inpatients of Internal Medicine, Endocrinology and Cardiology UnitsLaura Lohan, Florence Galtier, Thibault Manson, et al.
Diabetes & Metabolism|February 19, 2025
Semaglutide 2.4 mg in French people living with Class 3 obesity and comorbidities: Baseline characteristics and real-world safety dataEmmanuel Disse, Judith Aron-Wisnewsky, David Jacobi, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Clinical Biochemistry|December 12, 2017
Triglycerides and glycated hemoglobin for screening insulin resistance in obese patientsGuilaine Boursier, Ariane Sultan, Nicolas Molinari, et al.
Plos One|April 2, 2015
Effects of lifestyle interventions that include a physical activity component in class II and III obese individuals: a systematic review and meta-analysisAurélie Baillot, Ahmed J Romain, Katherine Boisvert-Vigneault, et al.
Appetite|May 6, 2024
Development and validation of the mindful eating scale (mind-eat scale) in a general populationMarion Van Beekum, Rebecca Shankland, Angélique Rodhain, et al.
Oxidative Medicine and Cellular Longevity|June 1, 2018
No Additive Effects of Polyphenol Supplementation and Exercise Training on White Adiposity Determinants of High-Fat Diet-Induced Obese Insulin-Resistant RatsKaren Lambert, Marie Hokayem, Claire Thomas, et al.
Obesity (Silver Spring, Md.)|November 6, 2023
Semaglutide 2.4 mg/wk for weight loss in patients with severe obesity and with or without a history of bariatric surgeryJean-Baptiste Bonnet, Sarah Tournayre, Jean Anitcheou, et al.
Endocrine Connections|May 6, 2022
In patients with anorexia nervosa, myokine levels are altered but are not associated with bone mineral density loss and bone turnover alterationLaurent Maïmoun, Denis Mariano-Goulart, Helena Huguet, et al.
Obesity (Silver Spring, Md.)|April 3, 2025
Clustering of intuitive eating and psychological health identifies subgroups associated with weight loss following semaglutideAntoine Avignon, Jean-Baptiste Bonnet, Jean Anitcheou, et al.
Bone|May 16, 2021
Modification of bone mineral density, bone geometry and volumetric BMD in young women with obesityLaurent Maïmoun, Eric Renard, Ludovic Humbert, et al.
Medicina (Kaunas, Lithuania)|December 24, 2021
Compliance with Prescription Guidelines for Glucose-Lowering Therapies According to Renal Function: Real-Life Study in Inpatients of Internal Medicine, Endocrinology and Cardiology UnitsLaura Lohan, Florence Galtier, Thibault Manson, et al.
Diabetes & Metabolism|February 19, 2025
Semaglutide 2.4 mg in French people living with Class 3 obesity and comorbidities: Baseline characteristics and real-world safety dataEmmanuel Disse, Judith Aron-Wisnewsky, David Jacobi, et al.
Pageof 8